These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 19617213)

  • 1. Left ventricular assist devices.
    Birks EJ
    Heart; 2010 Jan; 96(1):63-71. PubMed ID: 19617213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac recovery during mechanical assist device support.
    Maybaum S; Kamalakannan G; Murthy S
    Semin Thorac Cardiovasc Surg; 2008; 20(3):234-46. PubMed ID: 19038734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular assist device therapy.
    Sayer G; Naka Y; Jorde UP
    Cardiovasc Ther; 2009; 27(2):140-50. PubMed ID: 19426251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device therapy and cardiac transplantation for end-stage heart failure.
    Boilson BA; Raichlin E; Park SJ; Kushwaha SS
    Curr Probl Cardiol; 2010 Jan; 35(1):8-64. PubMed ID: 19962044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device as a bridge to partial left ventriculectomy.
    Frazier OH
    Eur J Cardiothorac Surg; 1999 Jan; 15 Suppl 1():S20-5; discussion S39-43. PubMed ID: 10077391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
    Klotz S; Jan Danser AH; Burkhoff D
    Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of cell transplantation with a left ventricular assist device to improve the success rate of left ventricular assist device removal: the first experiment.
    Mizuno T
    Interact Cardiovasc Thorac Surg; 2011 Jan; 12(1):10-4. PubMed ID: 20926461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The left ventricular assist device (LVAD). A bridge to heart transplantation.
    Camp D
    Crit Care Nurs Clin North Am; 2000 Mar; 12(1):61-8. PubMed ID: 11051919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacotherapy of the HeartMate II, a continuous flow left ventricular assist device, in patients with advanced heart failure: integration of disease, device, and drug.
    Jennings DL; Chambers RM; Schillig JM
    Ann Pharmacother; 2010 Oct; 44(10):1647-50. PubMed ID: 20841512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent mechanical circulatory support in patients of advanced age.
    Jurmann MJ; Weng Y; Drews T; Pasic M; Hennig E; Hetzer R
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):610-8. PubMed ID: 15037280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of the art: implantable ventricular assist devices.
    Lahpor JR
    Curr Opin Organ Transplant; 2009 Oct; 14(5):554-9. PubMed ID: 19667990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
    Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
    J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.
    Rogers JG; Aaronson KD; Boyle AJ; Russell SD; Milano CA; Pagani FD; Edwards BS; Park S; John R; Conte JV; Farrar DJ; Slaughter MS;
    J Am Coll Cardiol; 2010 Apr; 55(17):1826-34. PubMed ID: 20413033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current axial-flow devices--the HeartMate II and Jarvik 2000 left ventricular assist devices.
    John R
    Semin Thorac Cardiovasc Surg; 2008; 20(3):264-72. PubMed ID: 19038737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.